Latest Breaking News On - Dale muzzey - Page 1 : comparemela.com

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

SALT LAKE CITY, June 03, 2024 Myriad Genetics, Inc., , a leader in genetic testing and precision medicine, today announced that Genetics in Medicine, an official journal of the American College.

Genetics in Medicine Publishes Myriad Genetics

SALT LAKE CITY, June 03, 2024 (GLOBE NEWSWIRE) Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today.

New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer

Myriad’s Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1 SALT LAKE CITY, May 16, 2024 Myriad Genetics, Inc. , a.

Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

Myriad Genetics (MYGN) Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing